NCT02381418View on ClinicalTrials.gov

Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the Southern Hemisphere 2015 Season

PHASE3CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Influenza
Interventions
BIOLOGICAL

Trivalent influenza subunit vaccine Influvac

"3x 15mcg HA per 0.5 ml,trivalent one injection at Day 1 "

Trial Locations (1)

NSW 2035

Research Facility ID ORG-001075, Maroubra

Sponsors

Lead Sponsor

Abbott
All Listed Sponsors
lead

Abbott

INDUSTRY

NCT02381418 - Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the Southern Hemisphere 2015 Season | Biotech Hunter | Biotech Hunter